EDARBI 20mg tablets medication leaflet

C09CA09 azilsartan • Cardiovascular system | Angiotensin II receptor blockers (arbs), plain | Angiotensin ii receptor blockers (arbs), plain

Azilsartan is an angiotensin II receptor blocker (ARB) used in the treatment of hypertension. It works by blocking the AT1 receptors of angiotensin II, a hormone that causes vasoconstriction and sodium retention, thereby lowering blood pressure and reducing the risk of cardiovascular complications.

Azilsartan is administered orally, usually once daily, and can be used alone or in combination with other antihypertensive medications. It is indicated for adult patients with essential hypertension, providing effective and long-lasting blood pressure control.

Common side effects include dizziness, fatigue, nausea, and diarrhea. In rare cases, severe adverse reactions such as renal impairment, hyperkalemia, or allergic reactions may occur. Regular monitoring of blood pressure and renal function is essential during treatment.

Azilsartan is a modern and well-tolerated therapeutic option for managing hypertension, contributing to the reduction of major cardiovascular events.

General data about EDARBI 20mg

Substance: azilsartan

Date of last drug list: 01-01-2019

Commercial code: W58519002

Concentration: 20mg

Pharmaceutical form: tablets

Quantity: 28

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Concentrations available for azilsartan

20mg, 40mg, 80mg